Stock Analysts’ updated eps estimates for Thursday, November 14th:
AutoCanada (TSE:ACQ) was upgraded by analysts at National Bankshares, Inc. from a sector perform rating to an outperform rating. They currently have C$21.00 target price on the stock, up from their previous target price of C$17.00.
Astria Therapeutics (NASDAQ:ATXS) had its buy rating reiterated by analysts at HC Wainwright. The firm currently has a $16.00 price target on the stock.
Capricor Therapeutics (NASDAQ:CAPR) had its buy rating reissued by analysts at HC Wainwright. The firm currently has a $77.00 price target on the stock.
Checkpoint Therapeutics (NASDAQ:CKPT) had its buy rating reiterated by analysts at HC Wainwright. The firm currently has a $20.00 target price on the stock.
4D Molecular Therapeutics (NASDAQ:FDMT) had its buy rating reaffirmed by analysts at HC Wainwright. They currently have a $36.00 target price on the stock.
Hims & Hers Health (NYSE:HIMS) was downgraded by analysts at Bank of America Co. from a buy rating to an underperform rating.
IAC (NASDAQ:IAC) had its outperform rating reaffirmed by analysts at Macquarie. Macquarie currently has a $14.00 target price on the stock.
Kamada (NASDAQ:KMDA) had its buy rating reissued by analysts at HC Wainwright. HC Wainwright currently has a $11.00 target price on the stock.
Liquidia (NASDAQ:LQDA) had its buy rating reissued by analysts at HC Wainwright. The firm currently has a $29.00 target price on the stock.
Net Lease Office Properties (NYSE:NLOP) had its buy rating reiterated by analysts at BWS Financial. BWS Financial currently has a $46.00 target price on the stock.
PubMatic (NASDAQ:PUBM) had its neutral rating reissued by analysts at Macquarie. They currently have a $19.00 target price on the stock.
Pivotree (CVE:PVT) was downgraded by analysts at Cormark from a buy rating to a market perform rating.
Quantum (NASDAQ:QMCO) had its market perform rating reaffirmed by analysts at Northland Securities. They currently have a $5.00 target price on the stock, up from their previous target price of $0.25.
scPharmaceuticals (NASDAQ:SCPH) had its buy rating reiterated by analysts at HC Wainwright. HC Wainwright currently has a $18.00 target price on the stock.
Sangamo Therapeutics (NASDAQ:SGMO) had its buy rating reiterated by analysts at HC Wainwright. The firm currently has a $10.00 price target on the stock.
Shattuck Labs (NASDAQ:STTK) had its hold rating reissued by analysts at Needham & Company LLC.
Trevena (NASDAQ:TRVN) had its neutral rating reiterated by analysts at HC Wainwright. They currently have a $5.00 price target on the stock.
Receive News & Ratings for AutoCanada Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AutoCanada Inc and related companies with MarketBeat.com's FREE daily email newsletter.
